retatrutide mechanism triple agonist gip glp-1 glucagon Retatrutide: How GLP-1/GIP/Glucagon Receptor Agonism Differs From Existing Compounds Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

Januvia and Mounjaro Together: UK Guidance and Safer Alternatives Januvia (sitagliptin) and Mounjaro (tirzepatide) are both incretin-based therapies used to manage type 2 diabetes, but taking Januvia and Mounjaro together is not recommended in UK clinical practice

Seven participants tested positive for methanogenic SIBO at baseline, and none were methane SIBO negative at week 6

Participants receiving higher doses of the drug were more likely to experience mild-moderate GI issues, such as nausea, vomiting, diarrhoea, and constipation

Slowing Gastric Emptying: They slow down the rate at which the stomach empties, which can lead to prolonged feelings of fullness after meals, further assisting in controlling appetite

[10] [11] Interleukin-6 (IL-6): A cytokine involved in acute-phase inflammatory responses